FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma.
Abdelrahman AM, Goenka AH, Alva-Ruiz R, Yonkus JA, Leiting JL, Graham RP, Merrell KW, Thiels CA, Hallemeier CL, Warner SG, Haddock MG, Grotz TE, Tran NH, Smoot RL, Ma WW, Cleary SP, McWilliams RR, Nagorney DM, Halfdanarson TR, Kendrick ML, Truty MJ.
Abdelrahman AM, et al. Among authors: merrell kw.
J Natl Compr Canc Netw. 2022 Sep;20(9):1023-1032.e3. doi: 10.6004/jnccn.2022.7041.
J Natl Compr Canc Netw. 2022.
PMID: 36075389